HepaRegeniX GmbH ('HepaRegeniX”), a clinical-stage biotech company advancing novel therapies for acute and chronic liver ...

Early and accurate prognostic assessment is crucial to prevent disease progression in liver failure. Thyroid hormones (THs), ...

New research from the University of Kansas shows a "risk gene" linked to higher odds of developing autoimmune diseases such ...

Zurich (Switzerland), May 11, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced ...

Coming into the year, we outlined our key priorities for 2026, accelerating development of WVE-007, our INHIBNE GalNAc siRNA program for obesity and rapidly advancing our RNA editing portfolio led by ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the publication of a post-hoc win ...

Countries are making measurable progress in combatting viral hepatitis, but the disease remains a major global health challenge, the World Health Organization (WHO) said in a new report published on ...

The province is offering free immunization to those most at risk: people in the Island Lake area (Garden Hill, St. Theresa ...

Being able to drink more without feeling it isn’t a sign of strength — it’s a sign your body has adapted.

A rare hantavirus case in a postpartum Indian woman, previously undocumented, highlights the disease's unexpected severity and potential to strike vulnerable individuals. Meanwhile, a cruise ship ...

SAN ANTONIO - A San Antonio nurse who fell into a coma after suffering acute liver failure during her honeymoon in Japan is ...